Teva Agrees To Suspend Sales Of Moexipril Pending Patent Suit Outcome
Israeli generics maker Teva Pharmaceutical Industries Ltd. has agreed to stop selling its generic version of Schwarz Pharma AG's Univasc hypertension drug until the resolution of a patent infringement lawsuit in...To view the full article, register now.
Already a subscriber? Click here to view full article